Commerzbank Aktiengesellschaft FI Purchases 9,905 Shares of Embecta Corp. (NASDAQ:EMBC)

Commerzbank Aktiengesellschaft FI boosted its position in shares of Embecta Corp. (NASDAQ:EMBC) by 41.6% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 33,729 shares of the company’s stock after purchasing an additional 9,905 shares during the period. Commerzbank Aktiengesellschaft FI owned about 0.06% of Embecta worth $638,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the company. Public Employees Retirement System of Ohio increased its position in Embecta by 66.2% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 2,284 shares of the company’s stock valued at $34,000 after acquiring an additional 910 shares in the last quarter. Signaturefd LLC increased its position in Embecta by 1,254.4% in the 3rd quarter. Signaturefd LLC now owns 2,316 shares of the company’s stock valued at $35,000 after acquiring an additional 2,145 shares in the last quarter. National Bank of Canada FI increased its position in Embecta by 187.9% in the 3rd quarter. National Bank of Canada FI now owns 2,775 shares of the company’s stock valued at $44,000 after acquiring an additional 1,811 shares in the last quarter. NBC Securities Inc. acquired a new stake in Embecta in the 3rd quarter valued at about $44,000. Finally, Allworth Financial LP increased its position in Embecta by 200.1% in the 3rd quarter. Allworth Financial LP now owns 3,280 shares of the company’s stock valued at $49,000 after acquiring an additional 2,187 shares in the last quarter. 93.83% of the stock is owned by institutional investors.

Embecta Trading Up 1.1 %

EMBC opened at $10.74 on Monday. Embecta Corp. has a 1-year low of $9.93 and a 1-year high of $32.00. The firm has a 50-day moving average price of $13.13 and a two-hundred day moving average price of $15.55. The stock has a market capitalization of $618.41 million, a PE ratio of 11.18 and a beta of 0.73.

Embecta (NASDAQ:EMBC) last issued its quarterly earnings results on Friday, February 9th. The company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.46 by $0.15. Embecta had a net margin of 4.93% and a negative return on equity of 18.66%. The company had revenue of $277.30 million during the quarter, compared to analysts’ expectations of $264.92 million. During the same quarter in the previous year, the company earned $0.93 EPS. Embecta’s revenue was up .6% on a year-over-year basis. On average, research analysts predict that Embecta Corp. will post 2.14 EPS for the current year.

Embecta Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 15th. Stockholders of record on Wednesday, February 28th were given a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a dividend yield of 5.59%. The ex-dividend date was Tuesday, February 27th. Embecta’s dividend payout ratio is 63.16%.

Insider Transactions at Embecta

In other Embecta news, Director David F. Melcher purchased 2,000 shares of the stock in a transaction dated Monday, February 12th. The stock was bought at an average price of $16.25 per share, for a total transaction of $32,500.00. Following the transaction, the director now directly owns 45,080 shares in the company, valued at $732,550. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 0.28% of the stock is owned by corporate insiders.

About Embecta

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.